
The Novartis Patient Assistance Foundation primarily provides direct access to prescription medicines by donating medical products to individual patients. Its grants are delivered as high-value, in-kind medication support rather than traditional grants to organizations, indicating a focus on removing financial barriers to essential specialty drugs for uninsured or underinsured patients.
Extremely concentrated, with very large in-kind medical product donations recorded as a small number of high-dollar transactions to individual beneficiaries rather than many grants to organizations; repeat/ongoing product support model.
Novartis Patient Assistance Foundation Inc centers its giving on one activity: donating Novartis medications at no cost to eligible patients who cannot afford them. The foundation’s recent grants are not organization awards in the usual sense; they are medical product donations delivered directly to individuals in East Hanover, NJ. The largest recent grant listed was $3,097,009,871 in 2025 to Various Individuals for medical product donation, with similarly large awards in 2024 and 2023, showing a sustained pattern of in-kind patient support. Through its Patient Assistance Program, the foundation provides certain Novartis medicines to U.S. patients who meet income and insurance criteria, including people with uninsured or government insurance coverage. This makes the foundation a direct-access mechanism for prescription treatment rather than a conventional grantmaker to charities. Its beneficiary profile is centered on patients and individuals requiring medical products, with the listed recent grants all going to various individuals in the United States.
A central theme in the foundation’s work is medication access for patients who cannot pay for Novartis treatment. The Patient Assistance Program provides certain Novartis medications at no cost to eligible U.S. patients, including people who are uninsured or have government insurance and who meet income and other criteria. Another clear theme is direct support for outpatient treatment: the program is designed to help individuals continue prescribed therapy rather than fund institutional services. The foundation also operates through medical product donation, which is reflected in grants to Various Individuals for medical product donation in 2023, 2024, and 2025. Its stated geography includes the United States and U.S. territories.
The typical grant size is extremely high and tightly clustered: p25 is $2,871,233,973, the median is $2,871,408,726, and p75 is $2,871,583,478. That narrow spread suggests a highly standardized grantmaking pattern. The foundation’s recent grants also show recurrence across multiple years, with medical product donations recorded in 2023, 2024, and 2025. It is a regular funder and funds individuals directly rather than operating as a DAF or making program-related investments. The active program accepts unsolicited requests, and the program description ties eligibility to income, insurance status, and other criteria.
$8.8B
$382.9M
$3.4B
$3.2B
Most grants fall between $2.9B and $2.9B, with a median of $2.9B.
25th Percentile
$2.9B
Median
$2.9B
75th Percentile
$2.9B
About 100% of grants go to recipients in NJ.
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Notable grantees: Various Individuals
Grant activity is local and concentrated in New Jersey: 100% of grants go to recipients in NJ, and the top state by grant count is NJ. The recent grants list places recipients in East Hanover, NJ. The country distribution is entirely U.S.-based, with 3 grants and 100.0% in the United States. The active assistance program also reaches U.S. territories.
It provides certain Novartis medications at no cost through medical product donations. The recent grants are to Various Individuals for medical product donation, and the active Patient Assistance Program is designed for eligible U.S. patients who cannot afford their Novartis medication.
The Patient Assistance Program is for eligible U.S. patients who cannot afford their Novartis medication, including people who are uninsured or have government insurance. The program description also says applicants must meet income and other eligibility criteria.
Yes. The active Novartis Patient Assistance Foundation (NPAF) Patient Assistance Program accepts unsolicited requests, which indicates direct application access rather than invitation-only support.
The foundation’s grant sizes are very large and consistent. Its p25 is $2,871,233,973, the median is $2,871,408,726, and the p75 is $2,871,583,478.
The grants are local and go entirely to recipients in New Jersey. The grant recipient country distribution is all U.S., and the recent grants list places recipients in East Hanover, NJ.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| VARIOUS INDIVIDUALS | EAST HANOVER, NJ | $3,097,009,871 | 2025 | MEDICAL PRODUCT DONATION |
| VARIOUS INDIVIDUALS | EAST HANOVER, NJ | $2,871,059,220 | 2024 | MEDICAL PRODUCT DONATION |
| VARIOUS INDIVIDUALS | EAST HANOVER, NJ | $2,871,758,231 | 2023 | MEDICAL PRODUCT DONATION |
VARIOUS INDIVIDUALS
$3,097,009,871MEDICAL PRODUCT DONATION
VARIOUS INDIVIDUALS
$2,871,059,220MEDICAL PRODUCT DONATION
VARIOUS INDIVIDUALS
$2,871,758,231MEDICAL PRODUCT DONATION